These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 22678487)
1. Introduction to pharmacovigilance articles. Weller I Curr Opin HIV AIDS; 2012 Jul; 7(4):291. PubMed ID: 22678487 [No Abstract] [Full Text] [Related]
2. Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIV. Marcus KA; Sorbello A; Truffa M; Williams J; Raine JM; Powderly WG Curr Opin HIV AIDS; 2012 Jul; 7(4):292-8. PubMed ID: 22647589 [TBL] [Abstract][Full Text] [Related]
3. Current world literature. Curr Opin HIV AIDS; 2012 Jul; 7(4):376-81. PubMed ID: 22678490 [No Abstract] [Full Text] [Related]
4. Pharmacovigilance and global HIV/AIDS. Miller V; Nwokike J; Stergachis A Curr Opin HIV AIDS; 2012 Jul; 7(4):299-304. PubMed ID: 22627711 [TBL] [Abstract][Full Text] [Related]
5. Tribulations and trials in HIV disease, Part I. Boyle BA AIDS Read; 2006 May; 16(5):240-4. PubMed ID: 16764065 [No Abstract] [Full Text] [Related]
7. Preventing HIV infection in children. Steinbrook R N Engl J Med; 2002 Jun; 346(24):1842-3. PubMed ID: 12063367 [No Abstract] [Full Text] [Related]
8. The feminization of an epidemic. Women and HIV in the United States. Iobst S; Gandhi M Posit Aware; 2009; 20(4):34-9. PubMed ID: 19653375 [No Abstract] [Full Text] [Related]
9. The place of prevention in HIV clinical care: a roundtable discussion. O'Rourke M; Auerbach J; del Rio C; Dooley S; Friedland G; Ridzon R AIDS Clin Care; 2002 Jun; 14(6):49-53, 58. PubMed ID: 12061143 [No Abstract] [Full Text] [Related]
10. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy. Cohen J Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490 [No Abstract] [Full Text] [Related]
11. Reports on nevirapine threaten public health. Lane HC; Folkers GK; Fauci AS Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930 [No Abstract] [Full Text] [Related]
12. [HIV infection: antiretroviral therapy 1997. Consensus statement of the International AIDS Society-USA Panel]. Med Monatsschr Pharm; 1997 Dec; 20(12):343-6. PubMed ID: 9527604 [No Abstract] [Full Text] [Related]
13. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients. AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313 [No Abstract] [Full Text] [Related]
14. Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa. Ruud KW; Srinivas SC; Toverud EL Res Social Adm Pharm; 2010 Dec; 6(4):345-53. PubMed ID: 21111391 [TBL] [Abstract][Full Text] [Related]
15. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection. Krogstad PA J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216 [No Abstract] [Full Text] [Related]
16. Effective treatment options to be examined in 9-year study. AIDS Policy Law; 2002 Feb; 17(2):2. PubMed ID: 11851127 [No Abstract] [Full Text] [Related]
17. European guidelines for the clinical management and treatment of HIV-infected adults in Europe. AIDS; 2003 Jun; 17 Suppl 2():S3-26. PubMed ID: 12870523 [No Abstract] [Full Text] [Related]
18. Management of HIV: a swing back to the future. Alozie OK; Bonham S; Henry WK Minn Med; 2009 Oct; 92(10):45-9. PubMed ID: 19916274 [TBL] [Abstract][Full Text] [Related]
19. FDA notifications. Reyataz is approved for HIV treatment. AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309 [TBL] [Abstract][Full Text] [Related]
20. Shooting at a moving target: natural history studies and the rapidly improving state of anti-HIV treatment. McKinney RE J Pediatr; 2002 Sep; 141(3):301-2. PubMed ID: 12219046 [No Abstract] [Full Text] [Related] [Next] [New Search]